-
1
Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
Published 2025-01-01Subjects: “…Sodium–glucose cotransporter-2 inhibitors…”
Get full text
Article -
2
Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report
Published 2025-01-01Subjects: Get full text
Article -
3
Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
Published 2022-06-01Subjects: Get full text
Article -
4
Sodium-glucose cotransporter-2 inhibitors increase urinary tract infections?—a cross sectional analysis of a nationwide Japanese claims database
Published 2023-11-01Subjects: “…sodium-glucose cotransporter-2 inhibitor…”
Get full text
Article -
5
-
6
The road ahead: emerging therapies for primary IgA nephropathy
Published 2025-02-01Subjects: “…SGLT2 (sodium-glucose cotransporter 2) inhibitor…”
Get full text
Article -
7
-
8